Minimally Invasive Surgical Instruments Market By Product Type (Surgical Instruments {Handheld Instruments, Electrosurgical Instruments, Cutter Instruments, and Sutures and Stapling Devices}, Visualization & Imaging Systems {Endoscopes, Camera Systems & Light Sources}, Access & Guiding Instruments {Trocars and Cannulas, Needle Guides & Catheters, and Dilators}, Inflation Devices {Insufflators and Gas Flow Regulators}, Auxiliary & Support Devices {Suction & Irrigation Systems, Wound Closure Devices, Sterilization & Consumables}, Laser Devices, Robotic Surgery Instruments, and Others), By Application (Orthopedic Surgery, Cardiac Surgery, Neurosurgery, Gastrointestinal Surgery, Gynecology Surgery, Urology Surgery, Cosmetic & Plastic Surgery, and Others), By End-user (Hospitals, Ambulatory Surgery Centers, Specialty Clinics, and Others), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Industry Outlook

The Minimally Invasive Surgical Instruments market accounted for USD 34.8 Billion in 2024 and is expected to reach USD 107.5 Billion by 2035, growing at a CAGR of around 10.8% between 2025 and 2035.  Minimally invasive surgical instruments refer to the industry that develops and sells tools used in procedures requiring smaller incisions than traditional surgery. Examples of these instruments include endoscopes, robotic systems, forceps, and lasers, among others. In this case, the instruments enable the carrying out of more precise and less invasive procedures, resulting in quicker recovery times and reduced risk of infection.

Driven by such factors as the new technology-related progress, increased demand for less painful and more efficient options of surgery, as well as chronic diseases needing surgical intervention, key sectors include orthopedics, cardiovascular, and gastrointestinal surgeries. The market is expected to grow with innovation in robotics and AI. 

Report Scope:

Market Dynamics

Technological Innovations in Robotics and Imaging Propel Growth of Minimally Invasive Surgical Instruments Market

Technological improvements in minimally invasive surgical instruments are expanding the market at a faster pace. Robotic surgery, 3D imaging systems, and better visualization tools changed the nature of surgical procedures as these achieve more precision, quicker recovery, and lower rates of complications. As per the U.S. The National Library of Medicine reports that over 3,000 hospitals in the world have introduced robotic surgery systems like the da Vinci Surgical System, with the rate of growth in robot-assisted surgeries hitting 20% annually.

Technological innovations are enhancing surgical outcome results by increasing the usage of minimally invasive instruments, which are further enhanced by the increase in the market.  Integration of AI and machine learning for surgical robotics and imaging is adding further accuracy and efficiency to procedures, driving the overall market growth. As these technologies develop, demand for next-generation surgical instruments is likely to increase steadily.

Wearable Surgical Tools Boost Precision and Fuel Growth in Minimally Invasive Surgical Instruments Market

The advancements in wearable surgical tools are offering the market with substantial growth opportunities for the minimally invasive surgical instruments market. Advances, such as AR glasses, smart gloves, and exoskeletons, while performing surgery assist a surgeon in making more accurate and precise cuts. These technologies have the advantage of real-time guidance and improve accuracy while reducing human error, and therefore, the outcomes of surgical procedures are better.

Wearable devices also allow surgeons to conduct procedures involving high complexity with enhanced convenience and comfort, minimizing the fatigue that can occur from hours of surgery. Moreover, wearables also improve communication among surgical staff, making for an overall easier workflow of surgeries. Consequently, there is a growing demand for wearable surgical tools, and demand will continue to fuel this growth in the minimally invasive surgical instruments market.

Lack of Skilled Surgeons Hinders Widespread Adoption of Minimally Invasive Surgical Procedures

The greatest restraint to the growth of MIS instruments is the lack of skilled surgeons. The procedures dealing with minimally invasive surgery require specific training and experience with advanced tools and technologies. This can act as a barrier to adoption in some regions. Many surgical teams will lack knowledge in handling complex instruments, such as robotic systems, 3D imaging tools, or augmented reality devices.

Moreover, the enormous cost of training and the continuous retraining required might limit the number of qualified professionals that can be available. This lack of skilled surgeons is likely to postpone the widespread adaptation of MIS procedures, which in turn would limit market growth, especially in emerging economies, due to constrained access to specialized education. The higher the demand for MIS procedures, the greater the demand for trained personnel as a critical factor for optimal performance and safe surgeries.

Growth of Robotic-Assisted Surgery Presents Significant Opportunity for the Market

The growth of robotic-assisted surgery is generating greater opportunities for manufacturers in the market of minimally invasive surgical instruments. The da Vinci Surgical System and similar robotic surgery systems have increased in popularity because of their precision in performing complex surgeries with greater minerva and recovery time as short as possible for the patient.

Manufacturers can advance the creation of advanced robotic tools for surgeries as the use of these systems continues to grow throughout the world, further fueling future market expansion that should improve outcomes in surgery. Further, AI and machine learning would be integrated into robotic surgery to improve real-time decision-making, making the entire process more efficient and precise. This next step is predicted to result in a further surge in demand for robotic-assisted surgical instruments in the future.

Biocompatible Material Innovations Fuel Growth in Minimally Invasive Surgical Instruments Market

Advances in the development of biocompatible materials are creating significant opportunities for growth in the market for minimally invasive surgical instruments. Biodegradable polymers, enhanced alloys, and smart biomaterials allow for the creation of surgical tools that are more safe, effective, and capable of potentially offering a favorable reduction in complications. Advanced materials help enhance patient outcomes through quicker healing and minimize the possibility of infections or adverse reactions.

Application of biocompatible materials will make devices more durable, cost-effective, and environmentally friendly. As research continues in this field, the adoption of the technology behind these materials is expected to fuel further market growth, enhancing the safety, efficiency, and overall effectiveness of minimally invasive surgeries.

Industry Experts Opinion

"The FDA clearance of our Optimal Plating System marks a pivotal moment for Forma Medical and the orthopedic community at large, we are excited to introduce a transformative platform that not only enhances surgical outcomes but also elevates the standard of care for patients undergoing orthopedic foot and ankle procedures."

• Chris Cole, VP of Sales at Forma Medical

“PROstep MIS Lapidus puts the power back in our surgeon customers' hands to make the best decision for their patients. At Stryker, we're continuing to expand our surgery options to support our commitment to advancing minimally invasive foot and ankle surgery.”

• Patrick Fisher, Vice President and General Manager for Stryker’s

Segment Analysis

Based on the product type, the Minimally Invasive Surgical Instruments market has been classified into Surgical Instruments, Visualization & Imaging Systems, Access & Guiding Instruments, Inflation Devices, Auxiliary & Support Devices, Laser Devices, Robotic Surgery Instruments, and Others. The Surgical Instruments are further classified as Handheld Instruments, Electrosurgical Instruments, Cutter Instruments, and Sutures and Stapling Devices.

Based on Visualization & Imaging Systems the segment is classified as Endoscopes, Camera Systems & Light Sources. The Access & Guiding Instruments segment is classified as Trocars and Cannulas, Needle Guides & Catheters & Dilators. Inflation Devices are classified as Insufflators and Gas Flow Regulators. The Auxiliary & Support Devices segment is classified as Suction & Irrigation Systems, Wound Closure Devices, and Sterilization & Consumables.

Surgical instruments, especially handheld instruments, dominate the market because of their multifunctionality and ease of use. Handheld tools such as forceps, scissors, and scalpels are indispensable in surgeries to ensure accuracy and delicacy through small incisions that avoid maximum patient trauma and accelerate the recovery period. Their wide application in almost all surgical specialties contributes much to their market dominance. 

Based on the application, the Minimally Invasive Surgical Instruments market has been classified into orthopedic surgery, cardiac surgery, neurosurgery, gastrointestinal surgery, gynecology surgery, urology surgery, cosmetic and plastic surgery, and others. Orthopedic surgery is the leading segment in the market, owing to the increasing incidence of musculoskeletal disorders like arthritis, fractures, and sports injuries. The number of arthroscopic procedures for orthopedics has been increasing, while its recovery time is shorter and the risk for complications is relatively low, hence the popularity of minimally invasive techniques.

Regional Analysis

North America presents the largest market share in the Minimally Invasive Surgical Instruments market. This region has superior healthcare infrastructure, high healthcare expenditure, and an increasing elderly population. The U.S. is a front-runner in the region, as the use of modern medical technologies has gone more widespread, coupled with high demand for relatively minimally invasive procedures like orthopedic, cardiac, and cosmetic surgeries. Key players' presence along with continuous research and development activity added further to North America's position. Further, the awareness about the advantages of minimally invasive techniques such as less recuperation time and shorter durations of stay in hospitals is seen to fuel growth in this region.

Asia-Pacific holds a leading position in the growing Minimally Invasive Surgical Instruments market mainly because the region, with healthcare investments and medical infrastructure improvements in China, India, and Japan, is rapidly increasing. The demand for minimally invasive procedures, along with an increasingly middle-class population, is increasing awareness of more complex surgical techniques. Other factors driving the market in this region include an increased aging population and chronic diseases such as cardiovascular and orthopedic disorders. Governments in this region are promoting medical tourism, thereby contributing to the rapid adoption of minimally invasive surgeries and instruments.  

Competitive Landscape

The Minimally Invasive Surgical Instruments market is very competitive, with major companies including Medtronic, Johnson & Johnson, Stryker, Olympus, Intuitive Surgical, and Smith & Nephew holding the market's top share. These companies develop products continually by acquiring strategic designs and collaborating to stay at the leadership front of the market.

For instance, Intuitive Surgical developed the da Vinci Surgical System that further develops the robotic-assisted technologies to make more accurate minimally invasive surgeries possible. Stryker has, in addition, continued innovating with minimally invasive orthopedic solutions, especially in joint replacement. These new technologies align with the emerging trend in which advanced technologies, such as robotics, imaging systems, and AI are embedded in surgical tools with a strategy of enhancing patient outcomes and surgery accuracy, hence leading to the expansion of the surgery market.

Minimally Invasive Surgical Instruments Market, Company Shares Analysis, 2024

To explore in-depth analysis in this report - Request Free Sample Report

Recent Developments:

• In October 2024, LivsMed, a market and technology leader in minimally invasive surgical devices, announced the introduction of ArtiSential 5, the first 5mm wristed articulating laparoscopic instrument series to market. ArtiSential 5 marks a significant expansion of the company's award-winning ArtiSential line, providing greater flexibility and ease of use.
• In July 2024, Forma Medical Inc., an innovator of medical device technologies, announced that the OptimalMTP® Plating System has received 510(k) clearance from the FDA. This FDA clearance is a major step for the company in MIS or minimally invasive surgery. It brings a new wave of accuracy and efficiency to the practice of foot and ankle surgery.
• In March 2024, Voom™ Medical Devices, Inc. ("Voom"), a medical device company revolutionizing the minimally invasive bunion surgery (MIBS) education landscape, announced the launch of the new one-on-one surgeon training program for the Bunionplasty® 360 Bunion Repair ™ procedure.

Report Coverage:

By Product Type

• Surgical Instruments
  • Handheld Instruments
  • Electrosurgical Instruments
  • Cutter Instruments
  • Sutures and Stapling Devices
• Visualization & Imaging Systems
  • Endoscopes
  • Camera Systems & Light Sources
• Access & Guiding Instruments
  • Trocars and Cannulas
  • Needle Guides & Catheters
  • Dilators
• Inflation Devices
  • Insufflators
  • Gas Flow Regulators
• Auxiliary & Support Devices
  • Suction & Irrigation Systems
  • Wound Closure Devices
  • Sterilization & Consumables
• Laser Devices
• Robotic Surgery Instruments
• Others

By Application

• Orthopedic Surgery
• Cardiac Surgery
• Neurosurgery
• Gastrointestinal Surgery
• Gynecology Surgery
• Urology Surgery
• Cosmetic & Plastic Surgery
• Others

By End-user

• Hospitals
• Ambulatory Surgery Centers
• Specialty Clinics
• Others

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of the Middle East & Africa

List of Companies:

• Medtronic Plc
• Johnson & Johnson
• Stryker Corporation
• Olympus Corporation
• Karl Storz SE & Co. KG
• Smith & Nephew Plc
• Zimmer Biomet Holdings, Inc.
• Boston Scientific Corporation
• Intuitive Surgical, Inc.
• Hoya Corporation
• ConMed Corporation
• B. Braun Melsungen AG
• Abbott Laboratories
• Microline Surgical
• Cook Medical

Frequently Asked Questions (FAQs)